KorrekturOpen Access · CC BY-NC-ND 4.0
Correction to “Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: A multicenter real‐world study”
Alzheimer's & Dementia · 2026-04 · 22 (4)
DOI: 10.1002/alz.71347 ↗Kurz gefasst
Korrektur in der Zeitschrift Alzheimer's & Dementia, online erschienen am 08.04.2026. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: A multicenter real‐world study”. Alzheimer's & Dementia, 22(4). https://doi.org/10.1002/alz.71347
Vancouver
Correction to “Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: A multicenter real‐world study”. Alzheimer's & Dementia. 2026;22(4). doi:10.1002/alz.71347
BibTeX
@article{euvimed2026,
title = {Correction to “Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: A multicenter real‐world study”},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {4},
doi = {10.1002/alz.71347}
}
EUVIMED